Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease

OBJECTIVES: Treatment targets in inflammatory bowel disease (IBD) move away from controlling symptoms towards complete recovery of the intestinal mucosa. Currently, the most frequently used noninvasive surrogate marker of mucosal healing is a faecal calprotectin concentration in the target range. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Haisma, Sjoukje-Marije, Verkade, Henkjan J., Scheenstra, Rene, van der Doef, Hubert P.J., Bodewes, Frank A.J.A., van Rheenen, Patrick F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Articles: Gastroenterology: Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750145/
https://www.ncbi.nlm.nih.gov/pubmed/31365486
http://dx.doi.org/10.1097/MPG.0000000000002458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750145/
https://www.ncbi.nlm.nih.gov/pubmed/31365486
http://dx.doi.org/10.1097/MPG.0000000000002458

Ejemplares similares